Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent steps he has taken to increase awareness of the risk factors associated with prostate cancer.

Currently, the UK National Screening Committee (UK NSC) does not recommend a national prostate cancer screening programme due to the limitations of the current best test, the Prostate Specific Antigen test, which may lead to overdiagnosis and overtreatment of cancers that would not have caused harm during a man’s lifetime. However, the UK NSC is undertaking a comprehensive evidence review to assess six potential approaches to targeted screening for those at higher risk of developing prostate cancer. Recommendations will be published upon the conclusion of this review.

In addition, the Government has invested £16 million in the £42 million United Kingdom-wide TRANSFORM trial, led by Prostate Cancer UK, which aims to identify new ways of detecting prostate cancer at an earlier stage, including in men without symptoms. The trial will ensure that at least 10% of participants are black men, reflecting their higher risk and the importance of ensuring new tests are effective across all groups.

The UK NSC does not currently recommend a national screening programme for prostate cancer, as the current PSA test lacks the necessary accuracy. It can lead to overdiagnosis and unnecessary treatment, as well as false reassurance for some men. This is particularly important given that many prostate cancers are slow-growing and may not cause harm during a man's lifetime.

NHS England is taking steps to increase public understanding of prostate cancer and its risk factors. This includes working in partnership with Cancer Alliances, charities, and local representatives to reach people in their communities with tailored messaging and support.